Startups
Epiome
AI biotechnology company developing a computational brain-discovery platform for neurological drug research. It uses blood-sample data to infer cell-specific molecular and epigenetic features of the brain, aiming to identify biomarkers, disease mechanisms and drug targets without directly sampling brain tissue. Starting with Alzheimer’s disease, Epiome seeks to help pharmaceutical researchers stratify clinical trials and develop treatments that slow or prevent neurodegeneration. It combines machine learning with functional genomics and cell biology, pursuing both discovery services for pharmaceutical partners and an internal therapeutic pipeline. Its published founders are Rowan Rimington and Jessie Li.